| Dr Michael Trent Turner Jr, MD | |
|
8401 Datapoint Dr, Ste 500, San Antonio, TX 78229-5900 | |
| (210) 614-0180 | |
| (210) 615-7170 |
| Full Name | Dr Michael Trent Turner Jr |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 8401 Datapoint Dr, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154459584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | K3654 (Texas) | Secondary |
| 207P00000X | Emergency Medicine | K3654 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Trent Turner Jr, MD 8401 Datapoint Dr, Ste 500, San Antonio, TX 78229-5900 Ph: (210) 614-0180 | Dr Michael Trent Turner Jr, MD 8401 Datapoint Dr, Ste 500, San Antonio, TX 78229-5900 Ph: (210) 614-0180 |
News Archive
Health Care REIT, Inc. today announced it has successfully completed its public offering of 29,900,000 shares of common stock at a price of $56.00 per share for total gross proceeds of approximately $1.7 billion. Total shares sold includes 3,900,000 shares sold pursuant to the underwriters' exercise in full of their option to purchase additional shares.
A common birthday party favour can blow up into a problem for children-but also a bigger conversation about hearing loss, say University of Alberta researchers.
Novian Health, developer of Novilase® Breast Therapy, announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for the company to start a multi-center study of its Novilase® Interstitial Laser Therapy (ILT) System. Novian developed the ILT System for the ablation of small (up to 20 mm) malignant breast tumors.
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
On July 24, 2009, The NASDAQ Stock Market notified Commonwealth Biotechnologies, Inc. that CBI was to be delisted from the NASDAQ Capital Market as a result of a failure to comply with NASDAQ Listing Rule 5550(b) due to a failure to maintain minimum stockholders' equity of $2.5 million and a failure to file a Form 8-K affirming compliance with Rule 5550(b).
› Verified 3 days ago
Dr. Jeff Sensenig, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8401 Datapoint Dr, Ste 500, San Antonio, TX 78229 Phone: 210-614-0180 Fax: 210-615-7170 | |
Adam Clemens Benzing, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7719 S I-35 Frontage Road, San Antonio, TX 78232 Phone: 210-572-2955 | |
Dr. John F. Bragan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1610 Wood Quail, San Antonio, TX 78248 Phone: 210-416-4420 Fax: 210-492-4317 | |
Dr. Joseph Michael Martin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Alamosa Ave, San Antonio, TX 78210 Phone: 210-269-9372 | |
Luke Franklin Husby, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-450-9000 | |
Dr. Erica Lynn Hudson, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7930 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-297-5000 | |
Thomas Rex Bosen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7700 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-233-6363 |